233 related articles for article (PubMed ID: 36897523)
21. Gene silencing of CD47 and antibody ligation of thrombospondin-1 enhance ischemic tissue survival in a porcine model: implications for human disease.
Isenberg JS; Romeo MJ; Maxhimer JB; Smedley J; Frazier WA; Roberts DD
Ann Surg; 2008 May; 247(5):860-8. PubMed ID: 18438125
[TBL] [Abstract][Full Text] [Related]
22. Thrombospondin-1-CD47 blockade and exogenous nitrite enhance ischemic tissue survival, blood flow and angiogenesis via coupled NO-cGMP pathway activation.
Isenberg JS; Shiva S; Gladwin M
Nitric Oxide; 2009 Aug; 21(1):52-62. PubMed ID: 19481167
[TBL] [Abstract][Full Text] [Related]
23. The CD47-binding peptide of thrombospondin-1 induces defenestration of liver sinusoidal endothelial cells.
Venkatraman L; Tucker-Kellogg L
Liver Int; 2013 Oct; 33(9):1386-97. PubMed ID: 23799952
[TBL] [Abstract][Full Text] [Related]
24. CD47 signaling pathways controlling cellular differentiation and responses to stress.
Soto-Pantoja DR; Kaur S; Roberts DD
Crit Rev Biochem Mol Biol; 2015; 50(3):212-30. PubMed ID: 25708195
[TBL] [Abstract][Full Text] [Related]
25. CD47 regulates renal tubular epithelial cell self-renewal and proliferation following renal ischemia reperfusion.
Rogers NM; Zhang ZJ; Wang JJ; Thomson AW; Isenberg JS
Kidney Int; 2016 Aug; 90(2):334-347. PubMed ID: 27259369
[TBL] [Abstract][Full Text] [Related]
26. Age-associated induction of cell membrane CD47 limits basal and temperature-induced changes in cutaneous blood flow.
Rogers NM; Roberts DD; Isenberg JS
Ann Surg; 2013 Jul; 258(1):184-91. PubMed ID: 23275312
[TBL] [Abstract][Full Text] [Related]
27. Thrombospondin-1 inhibits nitric oxide signaling via CD36 by inhibiting myristic acid uptake.
Isenberg JS; Jia Y; Fukuyama J; Switzer CH; Wink DA; Roberts DD
J Biol Chem; 2007 May; 282(21):15404-15. PubMed ID: 17416590
[TBL] [Abstract][Full Text] [Related]
28. Activated CD47 promotes pulmonary arterial hypertension through targeting caveolin-1.
Bauer PM; Bauer EM; Rogers NM; Yao M; Feijoo-Cuaresma M; Pilewski JM; Champion HC; Zuckerbraun BS; Calzada MJ; Isenberg JS
Cardiovasc Res; 2012 Mar; 93(4):682-93. PubMed ID: 22215724
[TBL] [Abstract][Full Text] [Related]
29. Thrombospondin 1 in Metabolic Diseases.
Gutierrez LS; Gutierrez J
Front Endocrinol (Lausanne); 2021; 12():638536. PubMed ID: 33854480
[TBL] [Abstract][Full Text] [Related]
30. Upregulated TSP1 and CD47 expression in the lung in nitrofen-induced congenital diaphragmatic hernia.
Takayasu H
Pediatr Int; 2023 Jan; 65(1):e15447. PubMed ID: 36528876
[TBL] [Abstract][Full Text] [Related]
31. Regulation of Cellular Redox Signaling by Matricellular Proteins in Vascular Biology, Immunology, and Cancer.
Roberts DD; Kaur S; Isenberg JS
Antioxid Redox Signal; 2017 Oct; 27(12):874-911. PubMed ID: 28712304
[TBL] [Abstract][Full Text] [Related]
32. Thrombospondin-1 CD47 Signalling: From Mechanisms to Medicine.
Kale A; Rogers NM; Ghimire K
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920030
[TBL] [Abstract][Full Text] [Related]
33. Induction of vascular endothelial growth factor and matrix metalloproteinase-9 via CD47 signaling in neurovascular cells.
Xing C; Arai K; Park KP; Lo EH
Neurochem Res; 2010 Jul; 35(7):1092-7. PubMed ID: 20364320
[TBL] [Abstract][Full Text] [Related]
34. Transcriptional Regulation of Thrombospondins and Its Functional Validation through CRISPR/Cas9 Mediated Gene Editing in Corpus Luteum of Water Buffalo (Bubalus Bubalis).
Paul A; Bharati J; Punetha M; Kumar S; Mallesh VG; Chouhan VS; Sonwane A; Bag S; Bhure SK; Maurya VP; Singh G; Whitworth KM; Sarkar M
Cell Physiol Biochem; 2019; 52(3):532-552. PubMed ID: 30897320
[TBL] [Abstract][Full Text] [Related]
35. Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation.
Bauer EM; Qin Y; Miller TW; Bandle RW; Csanyi G; Pagano PJ; Bauer PM; Schnermann J; Roberts DD; Isenberg JS
Cardiovasc Res; 2010 Dec; 88(3):471-81. PubMed ID: 20610415
[TBL] [Abstract][Full Text] [Related]
36. CD47-dependent immunomodulatory and angiogenic activities of extracellular vesicles produced by T cells.
Kaur S; Singh SP; Elkahloun AG; Wu W; Abu-Asab MS; Roberts DD
Matrix Biol; 2014 Jul; 37():49-59. PubMed ID: 24887393
[TBL] [Abstract][Full Text] [Related]
37. CD47 and Nox1 Mediate Dynamic Fluid-Phase Macropinocytosis of Native LDL.
Csányi G; Feck DM; Ghoshal P; Singla B; Lin H; Nagarajan S; Meijles DN; Al Ghouleh I; Cantu-Medellin N; Kelley EE; Mateuszuk L; Isenberg JS; Watkins S; Pagano PJ
Antioxid Redox Signal; 2017 Jun; 26(16):886-901. PubMed ID: 27958762
[TBL] [Abstract][Full Text] [Related]
38. Matricellular protein thrombospondin-1 in pulmonary hypertension: multiple pathways to disease.
Rogers NM; Ghimire K; Calzada MJ; Isenberg JS
Cardiovasc Res; 2017 Jul; 113(8):858-868. PubMed ID: 28472457
[TBL] [Abstract][Full Text] [Related]
39. Divergent modulation of normal and neoplastic stem cells by thrombospondin-1 and CD47 signaling.
Kaur S; Roberts DD
Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):184-194. PubMed ID: 27163531
[TBL] [Abstract][Full Text] [Related]
40. HDAC6 Suppresses Let-7i-5p to Elicit TSP1/CD47-Mediated Anti-Tumorigenesis and Phagocytosis of Hepatocellular Carcinoma.
Yang HD; Kim HS; Kim SY; Na MJ; Yang G; Eun JW; Wang HJ; Cheong JY; Park WS; Nam SW
Hepatology; 2019 Oct; 70(4):1262-1279. PubMed ID: 30991448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
